264 related articles for article (PubMed ID: 17336934)
1. Prion inactivation by the Maillard reaction.
Suyama K; Yoshioka M; Akagawa M; Murayama Y; Horii H; Takata M; Yokoyama T; Mohri S
Biochem Biophys Res Commun; 2007 Apr; 356(1):245-8. PubMed ID: 17336934
[TBL] [Abstract][Full Text] [Related]
2. Protein misfolding cyclic amplification as a rapid test for assessment of prion inactivation.
Murayama Y; Yoshioka M; Horii H; Takata M; Yokoyama T; Sudo T; Sato K; Shinagawa M; Mohri S
Biochem Biophys Res Commun; 2006 Sep; 348(2):758-62. PubMed ID: 16890914
[TBL] [Abstract][Full Text] [Related]
3. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
4. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
5. Hyperefficient PrP Sc amplification of mouse-adapted BSE and scrapie strain by protein misfolding cyclic amplification technique.
Fujihara A; Atarashi R; Fuse T; Ubagai K; Nakagaki T; Yamaguchi N; Ishibashi D; Katamine S; Nishida N
FEBS J; 2009 May; 276(10):2841-8. PubMed ID: 19459939
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of a protein misfolding cyclic amplification for PrPSc].
Han J; Han L; Shi Q; Shi S; Wang X; Zhang BY; Dong XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):202-4. PubMed ID: 17971920
[TBL] [Abstract][Full Text] [Related]
7. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
[TBL] [Abstract][Full Text] [Related]
8. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
Piening N; Weber P; Giese A; Kretzschmar H
Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
[TBL] [Abstract][Full Text] [Related]
9. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
10. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups.
Lucassen R; Nishina K; Supattapone S
Biochemistry; 2003 Apr; 42(14):4127-35. PubMed ID: 12680767
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
[TBL] [Abstract][Full Text] [Related]
12. Tetracyclines affect prion infectivity.
Forloni G; Iussich S; Awan T; Colombo L; Angeretti N; Girola L; Bertani I; Poli G; Caramelli M; Grazia Bruzzone M; Farina L; Limido L; Rossi G; Giaccone G; Ironside JW; Bugiani O; Salmona M; Tagliavini F
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10849-54. PubMed ID: 12149459
[TBL] [Abstract][Full Text] [Related]
13. Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans.
Race R; Raines A; Raymond GJ; Caughey B; Chesebro B
J Virol; 2001 Nov; 75(21):10106-12. PubMed ID: 11581378
[TBL] [Abstract][Full Text] [Related]
14. Towards further reduction and replacement of animal bioassays in prion research by cell and protein misfolding cyclic amplification assays.
Boerner S; Wagenführ K; Daus ML; Thomzig A; Beekes M
Lab Anim; 2013 Apr; 47(2):106-15. PubMed ID: 23479773
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of mono-glycosylated form-rich, plaque-forming PrPSc in the second atypical bovine spongiform encephalopathy case in Japan.
Hagiwara K; Yamakawa Y; Sato Y; Nakamura Y; Tobiume M; Shinagawa M; Sata T
Jpn J Infect Dis; 2007 Sep; 60(5):305-8. PubMed ID: 17881874
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
17. PrPSc accumulation in myocytes from sheep incubating natural scrapie.
Andréoletti O; Simon S; Lacroux C; Morel N; Tabouret G; Chabert A; Lugan S; Corbière F; Ferré P; Foucras G; Laude H; Eychenne F; Grassi J; Schelcher F
Nat Med; 2004 Jun; 10(6):591-3. PubMed ID: 15156203
[TBL] [Abstract][Full Text] [Related]
18. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
[TBL] [Abstract][Full Text] [Related]
19. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
[TBL] [Abstract][Full Text] [Related]
20. Experimental transmission of two young and one suspended bovine spongiform encephalopathy (BSE) cases to bovinized transgenic mice.
Yokoyama T; Masujin K; Yamakawa Y; Sata T; Murayama Y; Shu Y; Okada H; Mohri S; Shinagawa M
Jpn J Infect Dis; 2007 Sep; 60(5):317-20. PubMed ID: 17881878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
